HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CTKB

Cytek Biosciences, Inc. (NASDAQ)

Healthcare — Medical Devices

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

None 4 analysts
$4.58
+$0.15 (+3.39%)
Target: $5.69 (24.2%)
Sign in to add CTKB to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$591.47M
P/E Ratio (TTM)-
Forward P/E24.11
EPS (TTM)$-0.58
Dividend Yield-
Profit Margin-36.25%
Revenue Growth6.50%
ROE-20.93%
Debt/Equity8.39
Recommendation None
Analyst Target$5.69
Analysts4
Indexes NASDAQ

Technical Indicators

RSI (14)65.7
Beta1.19
SMA 20-
SMA 40-
52-Week High$6.18
52-Week Low$3.09
50-Day Avg$4.19
200-Day Avg$4.49
Avg Volume$1.33M
Volume$1.16M

Performance Analysis

BULLISH

CTKB shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 48% of its 52-week range.
+ RSI at 65.7 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 6.5% year-over-year.
- Operating at a loss with -36.2% margin.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $5.69 implies 24.2% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:04 UTC

Back to Screener Export Report